$CRXX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in EPIRUS Biopharmaceuticals, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in EPIRUS Biopharmaceuticals, Inc.. Get notifications about new insider transactions in EPIRUS Biopharmaceuticals, Inc. for free.

Page: < prev 1 2 3 4 5 5 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Oct 13 2011	CRXX	EPIRUS Biopharmace ...	EVNIN LUKE	10% Owner	Sell	S	102.00	131,800	13,443,600	13,000,229	13.1 M to 13 M (-1.00 %)
Oct 13 2011	CRXX	EPIRUS Biopharmace ...	EVNIN LUKE	10% Owner	Sell	S	1.02	206,500	210,630	13,132,029	13.3 M to 13.1 M (-1.55 %)
Oct 11 2011	CRXX	EPIRUS Biopharmace ...	EVNIN LUKE	10% Owner	Sell	S	1.04	230,000	239,200	13,338,529	13.6 M to 13.3 M (-1.70 %)
Oct 11 2011	CRXX	EPIRUS Biopharmace ...	EVNIN LUKE	10% Owner	Sell	S	1.03	275,200	283,456	13,568,529	13.8 M to 13.6 M (-1.99 %)
Oct 11 2011	CRXX	EPIRUS Biopharmace ...	MPM BIOVENTURES III LLC	10% Owner	Sell	S	1.04	230,000	239,200	13,338,529	13.6 M to 13.3 M (-1.70 %)
Oct 11 2011	CRXX	EPIRUS Biopharmace ...	MPM BIOVENTURES III LLC	10% Owner	Sell	S	1.03	275,200	283,456	13,568,529	13.8 M to 13.6 M (-1.99 %)
Oct 06 2011	CRXX	EPIRUS Biopharmace ...	MPM BIOVENTURES III LLC	10% Owner	Sell	S	1.02	170,000	173,400	13,843,729	14 M to 13.8 M (-1.21 %)
Oct 06 2011	CRXX	EPIRUS Biopharmace ...	MPM BIOVENTURES III LLC	10% Owner	Sell	S	1.02	33,124	33,786	14,013,729	14 M to 14 M (-0.24 %)
Oct 06 2011	CRXX	EPIRUS Biopharmace ...	MPM BIOVENTURES III LLC	10% Owner	Sell	S	1.02	23,308	23,774	14,046,853	14.1 M to 14 M (-0.17 %)
Oct 06 2011	CRXX	EPIRUS Biopharmace ...	MPM BIOVENTURES III LLC	10% Owner	Sell	S	1.02	53,800	54,876	14,070,161	14.1 M to 14.1 M (-0.38 %)
Oct 06 2011	CRXX	EPIRUS Biopharmace ...	MPM BIOVENTURES III LLC	10% Owner	Sell	S	1.02	100,000	102,000	14,123,961	14.2 M to 14.1 M (-0.70 %)
Oct 06 2011	CRXX	EPIRUS Biopharmace ...	EVNIN LUKE	10% Owner	Sell	S	1.02	170,000	173,400	13,843,729	14 M to 13.8 M (-1.21 %)
Oct 06 2011	CRXX	EPIRUS Biopharmace ...	EVNIN LUKE	10% Owner	Sell	S	1.02	33,124	33,786	14,013,729	14 M to 14 M (-0.24 %)
Oct 06 2011	CRXX	EPIRUS Biopharmace ...	EVNIN LUKE	10% Owner	Sell	S	1.02	23,308	23,774	14,046,853	14.1 M to 14 M (-0.17 %)
Oct 06 2011	CRXX	EPIRUS Biopharmace ...	EVNIN LUKE	10% Owner	Sell	S	1.02	53,800	54,876	14,070,161	14.1 M to 14.1 M (-0.38 %)
Oct 06 2011	CRXX	EPIRUS Biopharmace ...	EVNIN LUKE	10% Owner	Sell	S	1.02	100,000	102,000	14,123,961	14.2 M to 14.1 M (-0.70 %)
Sep 28 2011	CRXX	EPIRUS Biopharmace ...	EVNIN LUKE	10% Owner	Sell	S	1.09	200,000	218,000	14,223,961	14.4 M to 14.2 M (-1.39 %)
Sep 28 2011	CRXX	EPIRUS Biopharmace ...	EVNIN LUKE	10% Owner	Sell	S	1.11	210,000	233,100	14,423,961	14.6 M to 14.4 M (-1.44 %)
Sep 28 2011	CRXX	EPIRUS Biopharmace ...	MPM BIOVENTURES III LLC	10% Owner	Sell	S	1.09	200,000	218,000	14,223,961	14.4 M to 14.2 M (-1.39 %)
Sep 28 2011	CRXX	EPIRUS Biopharmace ...	MPM BIOVENTURES III LLC	10% Owner	Sell	S	1.11	210,000	233,100	14,423,961	14.6 M to 14.4 M (-1.44 %)
Jul 13 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	M	0.95	54,687	51,953	240,626
Jul 13 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	M	1.07	18,510	19,806	23,799
Jul 13 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	M	1.07	5,784	6,189	1,954
Jul 13 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	M	1.07	1,117	1,195	0
Jul 13 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	M	1.07	3,348	3,582	5,023
Jul 13 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	M	1.07	42,188	45,141	32,813
Jul 13 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Sell	S	2.70	54,687	147,655	11,256	65.9 K to 11.3 K (-82.93 %)
Jul 13 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Buy	M	0.95	54,687	51,953	65,943	11.3 K to 65.9 K (+485.85 %)
Jul 13 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Sell	S	2.70	70,947	191,557	11,256	82.2 K to 11.3 K (-86.31 %)
Jul 13 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Buy	M	1.07	70,947	75,913	82,203	11.3 K to 82.2 K (+630.30 %)
Jun 13 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	M	0.95	54,687	51,953	295,313
Jun 13 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	M	1.07	75	80	7,738
Jun 13 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	M	1.07	4,837	5,176	1,117
Jun 13 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	M	1.07	18,416	19,705	8,371
Jun 13 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	M	1.07	47,620	50,953	0
Jun 13 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Sell	S	2.33	54,687	127,421	11,256	65.9 K to 11.3 K (-82.93 %)
Jun 13 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Buy	M	0.95	54,687	51,953	65,943	11.3 K to 65.9 K (+485.85 %)
Jun 13 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Sell	S	2.33	70,948	165,309	11,256	82.2 K to 11.3 K (-86.31 %)
Jun 13 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Buy	M	1.07	70,948	75,914	82,204	11.3 K to 82.2 K (+630.31 %)
May 26 2011	CRXX	EPIRUS Biopharmace ...	Richardson Hartley T	Director	Option Exercise	A	2.40	15,000	36,000	15,000
May 26 2011	CRXX	EPIRUS Biopharmace ...	OSHEA WILLIAM J	Director	Option Exercise	A	2.40	15,000	36,000	15,000
May 26 2011	CRXX	EPIRUS Biopharmace ...	Kauffman Michael	Director	Option Exercise	A	2.40	15,000	36,000	15,000
May 26 2011	CRXX	EPIRUS Biopharmace ...	Hunter William L	Director	Option Exercise	A	2.40	15,000	36,000	15,000
May 26 2011	CRXX	EPIRUS Biopharmace ...	HAYDU FRANK	Director	Option Exercise	A	2.40	15,000	36,000	15,000
May 26 2011	CRXX	EPIRUS Biopharmace ...	Foley Todd	Director	Option Exercise	A	2.40	15,000	36,000	15,000
May 26 2011	CRXX	EPIRUS Biopharmace ...	CRAWFORD SALLY	Director	Option Exercise	A	2.40	15,000	36,000	15,000
Feb 10 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	A	2.65	100,000	265,000	100,000
Feb 10 2011	CRXX	EPIRUS Biopharmace ...	Renz Justin A	SVP, CFO & Treasure ...	Option Exercise	A	2.65	100,000	265,000	100,000
Feb 10 2011	CRXX	EPIRUS Biopharmace ...	CORRIGAN MARK	President & CEO	Option Exercise	A	2.65	300,000	795,000	300,000
Jan 28 2011	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Sell	S	2.03	2,319	4,708	17,506	19.8 K to 17.5 K (-11.70 %)
Jan 20 2011	CRXX	EPIRUS Biopharmace ...	CORRIGAN MARK	President & CEO	Sell	S	2.18	62,160	135,509	775,045	837.2 K to 775 K (-7.42 %)
Sep 10 2010	CRXX	EPIRUS Biopharmace ...	OSHEA WILLIAM J	Director	Option Exercise	A	1.33	15,000	19,950	15,000
Sep 10 2010	CRXX	EPIRUS Biopharmace ...	Richardson Hartley T	Director	Option Exercise	A	1.33	15,000	19,950	15,000
Sep 10 2010	CRXX	EPIRUS Biopharmace ...	Kauffman Michael	Director	Option Exercise	A	1.33	15,000	19,950	15,000
Sep 10 2010	CRXX	EPIRUS Biopharmace ...	HAYDU FRANK	Director	Option Exercise	A	1.33	15,000	19,950	15,000
Sep 10 2010	CRXX	EPIRUS Biopharmace ...	Hunter William L	Director	Option Exercise	A	1.33	15,000	19,950	15,000
Sep 10 2010	CRXX	EPIRUS Biopharmace ...	Foley Todd	Director	Option Exercise	A	1.33	15,000	19,950	15,000
Sep 10 2010	CRXX	EPIRUS Biopharmace ...	CRAWFORD SALLY	Director	Option Exercise	A	1.33	15,000	19,950	15,000
Apr 26 2010	CRXX	EPIRUS Biopharmace ...	Richardson Hartley T	Director	Buy	P	1.36	343	466	199,700	199.4 K to 199.7 K (+0.17 %)
Apr 15 2010	CRXX	EPIRUS Biopharmace ...	Richardson Hartley T	Director	Buy	P	1.24	161,200	199,888	199,357	38.2 K to 199.4 K (+422.47 %)
Mar 03 2010	CRXX	EPIRUS Biopharmace ...	Gallen Christopher C.	EVP Research & Deve ...	Grant	A	0.00	253,253	0	1,492,986	1.2 M to 1.5 M (+20.43 %)
Mar 03 2010	CRXX	EPIRUS Biopharmace ...	Gallen Christopher C.	EVP Research & Deve ...	Payment of Exercise	F	1.11	106,073	117,741	1,239,733	1.3 M to 1.2 M (-7.88 %)
Mar 03 2010	CRXX	EPIRUS Biopharmace ...	Wright C. Eugene	SVP & Chief Dev Off ...	Grant	A	0.00	48,280	0	48,280	0 to 48.3 K
Mar 03 2010	CRXX	EPIRUS Biopharmace ...	Wright C. Eugene	SVP & Chief Dev Off ...	Payment of Exercise	F	1.11	23,586	26,180	0	23.6 K to 0 (-100.00 %)
Mar 03 2010	CRXX	EPIRUS Biopharmace ...	CORRIGAN MARK	President & CEO	Grant	A	0.00	750,000	0	837,205	87.2 K to 837.2 K (+860.04 %)
Mar 03 2010	CRXX	EPIRUS Biopharmace ...	CORRIGAN MARK	President & CEO	Grant	A	0.00	49,048	0	87,205	38.2 K to 87.2 K (+128.54 %)
Mar 03 2010	CRXX	EPIRUS Biopharmace ...	CORRIGAN MARK	President & CEO	Payment of Exercise	F	1.11	22,817	25,327	38,157	61 K to 38.2 K (-37.42 %)
Mar 03 2010	CRXX	EPIRUS Biopharmace ...	Snutch Terrance P.	SVP & Chief Scienti ...	Grant	A	0.00	202,301	0	602,603	400.3 K to 602.6 K (+50.54 %)
Mar 03 2010	CRXX	EPIRUS Biopharmace ...	Snutch Terrance P.	SVP & Chief Scienti ...	Payment of Exercise	F	1.11	157,025	174,298	400,302	557.3 K to 400.3 K (-28.17 %)
Mar 03 2010	CRXX	EPIRUS Biopharmace ...	Hunter William L	Director	Grant	A	0.00	71,865	0	110,022	38.2 K to 110 K (+188.34 %)
Jan 28 2010	CRXX	EPIRUS Biopharmace ...	Cole Jason	Senior VP & General ...	Sell	S	0.93	2,542	2,356	19,825	22.4 K to 19.8 K (-11.36 %)
Jan 20 2010	CRXX	EPIRUS Biopharmace ...	Wright C. Eugene	Director	Option Exercise	A	0.95	47,862	45,469	47,862
Jan 20 2010	CRXX	EPIRUS Biopharmace ...	Wright C. Eugene	Director	Option Exercise	A	0.95	302,138	287,031	302,138
Jan 20 2010	CRXX	EPIRUS Biopharmace ...	Snutch Terrance P.	SVP & CSO	Option Exercise	A	0.95	100,000	95,000	100,000
Jan 20 2010	CRXX	EPIRUS Biopharmace ...	Richardson Hartley T	Director	Option Exercise	A	0.95	15,000	14,250	15,000
Jan 20 2010	CRXX	EPIRUS Biopharmace ...	Renz Justin A	SVP & CFO	Option Exercise	A	0.95	47,862	45,469	47,862
Jan 20 2010	CRXX	EPIRUS Biopharmace ...	Renz Justin A	SVP & CFO	Option Exercise	A	0.95	302,138	287,031	302,138
Jan 20 2010	CRXX	EPIRUS Biopharmace ...	OSHEA WILLIAM J	Director	Option Exercise	A	0.95	15,000	14,250	15,000
Jan 20 2010	CRXX	EPIRUS Biopharmace ...	Kauffman Michael	Director	Option Exercise	A	0.95	15,000	14,250	15,000
Jan 20 2010	CRXX	EPIRUS Biopharmace ...	Hunter William L	Director	Option Exercise	A	0.95	15,000	14,250	15,000
Jan 20 2010	CRXX	EPIRUS Biopharmace ...	HAYDU FRANK	Director	Option Exercise	A	0.95	15,000	14,250	15,000
Jan 20 2010	CRXX	EPIRUS Biopharmace ...	Gallen Christopher C.	EVP, Research & Dev ...	Option Exercise	A	0.95	59,737	56,750	59,737
Jan 20 2010	CRXX	EPIRUS Biopharmace ...	Gallen Christopher C.	EVP, Research & Dev ...	Option Exercise	A	0.95	120,263	114,250	120,263
Jan 20 2010	CRXX	EPIRUS Biopharmace ...	Foley Todd	Director	Option Exercise	A	0.95	15,000	14,250	15,000
Jan 20 2010	CRXX	EPIRUS Biopharmace ...	CRAWFORD SALLY	Director	Option Exercise	A	0.95	15,000	14,250	15,000
Jan 20 2010	CRXX	EPIRUS Biopharmace ...	CORRIGAN MARK	Director	Option Exercise	A	0.95	1,090,461	1,035,938	1,090,461
Jan 20 2010	CRXX	EPIRUS Biopharmace ...	CORRIGAN MARK	Director	Option Exercise	A	0.95	409,539	389,062	409,539
Jan 20 2010	CRXX	EPIRUS Biopharmace ...	Cole Jason	Senior VP & General ...	Option Exercise	A	0.95	47,862	45,469	47,862
Jan 20 2010	CRXX	EPIRUS Biopharmace ...	Cole Jason	Senior VP & General ...	Option Exercise	A	0.95	302,138	287,031	302,138
Jan 05 2010	CRXX	EPIRUS Biopharmace ...	Richardson Hartley T	Director	Sell	J	0.00	3,137,569	0	6,426,834	9.6 M to 6.4 M (-32.80 %)
Jan 05 2010	CRXX	EPIRUS Biopharmace ...	Richardson Hartley T	Director	Sell	J	0.00	30,111	0	38,157	68.3 K to 38.2 K (-44.11 %)
Jan 05 2010	CRXX	EPIRUS Biopharmace ...	Hunter William L	Director	Sell	J	0.00	30,111	0	38,157	68.3 K to 38.2 K (-44.11 %)
Jan 05 2010	CRXX	EPIRUS Biopharmace ...	CORRIGAN MARK	Director	Sell	J	0.00	30,111	0	38,157	68.3 K to 38.2 K (-44.11 %)
Jan 05 2010	CRXX	EPIRUS Biopharmace ...	Snutch Terrance P.	SVP & Chief Scienti ...	Sell	J	0.00	23,809	0	30,173	54 K to 30.2 K (-44.11 %)
Jan 05 2010	CRXX	EPIRUS Biopharmace ...	Snutch Terrance P.	SVP & Chief Scienti ...	Sell	J	0.00	315,852	0	400,302	716.2 K to 400.3 K (-44.10 %)
Jan 05 2010	CRXX	EPIRUS Biopharmace ...	Gallen Christopher C.	President &CEO	Sell	J	0.00	978,291	0	1,239,733	2.2 M to 1.2 M (-44.11 %)
Jan 04 2010	CRXX	EPIRUS Biopharmace ...	MPM BIOVENTURES III LLC	10% Owner	Sell	J	0.00	7,913,653	0	14,633,961	22.5 M to 14.6 M (-35.10 %)
Jan 04 2010	CRXX	EPIRUS Biopharmace ...	EVNIN LUKE	10% Owner	Sell	J	0.00	7,913,653	0	14,633,961	22.5 M to 14.6 M (-35.10 %)
Dec 24 2009	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	0.80	1,863,000	1,490,400	6,830,972	8.7 M to 6.8 M (-21.43 %)
Dec 24 2009	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	0.80	538,000	430,400	8,693,972	9.2 M to 8.7 M (-5.83 %)
Dec 24 2009	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	0.80	776,899	621,519	9,231,972	10 M to 9.2 M (-7.76 %)
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	A	1.07	42,309	45,271	42,309
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	D	3.43	55,000	188,650	0
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	A	1.07	75,001	80,251	75,001
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	D	4.57	97,500	445,575	0
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	A	1.07	7,813	8,360	7,813
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	D	6.47	12,500	80,875	0
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	A	1.07	26,787	28,662	26,787
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	D	8.79	56,250	494,438	0
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	A	1.07	5,954	6,371	5,954
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	D	8.35	12,500	104,375	0
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	A	1.07	47,620	50,953	47,620
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Cole Jason	SVP & General Couns ...	Option Exercise	D	10.68	100,000	1,068,000	0
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Renz Justin A	SVP & Chief Financi ...	Option Exercise	A	1.07	15,385	16,462	15,385
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Renz Justin A	SVP & Chief Financi ...	Option Exercise	D	3.43	20,000	68,600	0
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Renz Justin A	SVP & Chief Financi ...	Option Exercise	A	1.07	30,770	32,924	30,770
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Renz Justin A	SVP & Chief Financi ...	Option Exercise	D	4.57	40,000	182,800	0
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Renz Justin A	SVP & Chief Financi ...	Option Exercise	A	1.07	4,763	5,096	4,763
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Renz Justin A	SVP & Chief Financi ...	Option Exercise	D	8.79	10,000	87,900	0
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Renz Justin A	SVP & Chief Financi ...	Option Exercise	A	1.07	43,751	46,814	43,751
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Renz Justin A	SVP & Chief Financi ...	Option Exercise	D	5.85	70,000	409,500	0
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP and COO	Option Exercise	A	1.07	67,308	72,020	67,308
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP and COO	Option Exercise	D	3.43	87,500	300,125	0
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP and COO	Option Exercise	A	1.07	115,386	123,463	115,386
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP and COO	Option Exercise	D	4.57	150,000	685,500	0
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP and COO	Option Exercise	A	1.07	15,626	16,720	15,626
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP and COO	Option Exercise	D	6.47	25,000	161,750	0
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP and COO	Option Exercise	A	1.07	42,858	45,858	42,858
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP and COO	Option Exercise	D	8.79	90,000	791,100	0
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP and COO	Option Exercise	A	1.07	11,906	12,739	11,906
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP and COO	Option Exercise	D	8.35	25,000	208,750	0
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP and COO	Option Exercise	A	1.07	41,667	44,584	41,667
Dec 22 2009	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP and COO	Option Exercise	D	8.21	87,500	718,375	0
Jan 28 2009	CRXX	EPIRUS Biopharmace ...	Cole Jason	Senior VP & General ...	Sell	S	0.63	2,633	1,659	22,367	25 K to 22.4 K (-10.53 %)
Jan 28 2009	CRXX	EPIRUS Biopharmace ...	Forrester Robert	EVP & CFO	Sell	S	0.63	2,632	1,665	21,383	24 K to 21.4 K (-10.96 %)
Jan 28 2009	CRXX	EPIRUS Biopharmace ...	Borisy Alexis	CEO & President	Sell	S	0.63	5,256	3,302	312,204	317.5 K to 312.2 K (-1.66 %)
Dec 09 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.57	28,000	15,960	10,008,871	10 M to 10 M (+0.28 %)
Dec 09 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.57	8,000	4,560	9,980,871	10 M to 10 M (+0.08 %)
Dec 09 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.57	11,000	6,270	9,972,871	10 M to 10 M (+0.11 %)
Dec 09 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.57	3,000	1,709	9,961,871	10 M to 10 M (+0.03 %)
Dec 09 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.57	1,000	570	9,958,871	10 M to 10 M (+0.01 %)
Dec 09 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.57	1,700	969	9,957,871	10 M to 10 M (+0.02 %)
Dec 09 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.57	878,000	500,460	9,956,171	9.1 M to 10 M (+9.67 %)
Dec 09 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.57	245,000	139,650	9,078,171	8.8 M to 9.1 M (+2.77 %)
Dec 09 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.57	354,872	202,277	8,833,171	8.5 M to 8.8 M (+4.19 %)
Dec 05 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.55	6,000	3,300	8,478,299	8.5 M to 8.5 M (+0.07 %)
Dec 05 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.55	2,000	1,100	8,472,299	8.5 M to 8.5 M (+0.02 %)
Dec 05 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.55	2,300	1,265	8,470,299	8.5 M to 8.5 M (+0.03 %)
Dec 05 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.54	8,000	4,308	8,467,999	8.5 M to 8.5 M (+0.09 %)
Dec 05 2008	CRXX	EPIRUS Biopharmace ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	0.54	2,000	1,077	8,459,999	8.5 M to 8.5 M (+0.02 %)

Page: < prev 1 2 3 4 5 5 next >